EP
Epigral Limited
EPIGRAL.NS · NSE
₹1,108.00 +0.60% (+₹6.60)
1M -1.84%
Market Cap ₹47.5B
P/E Ratio 17.51x
Div. Yield -
ROE 12.54%
Bulios Fair Price
₹876.52
20.9% downside
Current Price
₹1,108
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EPIGRAL.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
49 /100
Fair P/E 17.51x
EV/EBITDA 8.07x
PEG 0.16x
Growth
92 /100
Growing EPS growth 11.65%
Rev. growth 18.06%
Book val. growth 37.92%
Profitability
71 /100
Strong Gross margin 29.49%
Net margin 10.32%
FCF margin 1.20%
Quality
77 /100
Excellent ROE 12.54%
ROIC N/A
ROA N/A
Debt
99 /100
Low Debt/Equity 0.00x
Int. coverage 7.50x
Net debt/EBITDA 0.00x
Stability
54 /100
Moderate Beta 0.21x
Rev. volatility 29.01%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EPIGRAL.NS
Online
Sector
Basic Materials
Industry
Chemicals
CEO
Kaushal Ashisbhai Soparkar
Employees
1,135
Headquarters
Ahmedabad
Upcoming events
05 NOV
Earnings
Upcoming earnings report